http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102061458-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42 |
| filingDate | 2019-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102061458-B1 |
| titleOfInvention | Pyrimidine-2-amine derivative, a method for producing the same, and an anticancer drug containing the same |
| abstract | The present invention relates to a pyrimidin-2-amine derivative, a preparation method thereof, and an anticancer agent comprising the same. The pyrimidin-2-amine derivative represented by Chemical Formula 1 according to the present invention has an excellent effect of inhibiting Aurora A kinase activity. Therefore, it may be useful as an anticancer agent. |
| priorityDate | 2019-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 282.